levofloxacin has been researched along with Pneumonia, Staphylococcal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laohavaleeson, S; Nicolau, DP; Tessier, PR | 1 |
| Bongiorno, D; Cafiso, V; Campanile, F; Crapis, M; Cristini, F; Sartor, A; Scarparo, C; Spina, D; Stefani, S; Viale, P | 1 |
| Boulanger, BR; Fogarty, C; Fowler, C; Kahn, JB; Morgan, N; Oross, M; Tennenberg, A; West, M; Wiesinger, B; Wu, SC | 1 |
| Corrado, M; Drusano, GL; Fowler, C; Kahn, J; Preston, SL; Weisinger, B | 1 |
2 trial(s) available for levofloxacin and Pneumonia, Staphylococcal
| Article | Year |
|---|---|
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Prospective Studies; Pseudomonas aeruginosa | 2003 |
Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Area Under Curve; Cross Infection; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcus aureus; Treatment Outcome | 2004 |
2 other study(ies) available for levofloxacin and Pneumonia, Staphylococcal
| Article | Year |
|---|---|
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus | 2008 |
Pathotype and susceptibility profile of a community-acquired methicillin-resistant Staphylococcus aureus strain responsible for a case of severe pneumonia.
Topics: Adult; Bacterial Proteins; Bacterial Toxins; Community-Acquired Infections; DNA Primers; Exotoxins; Humans; Italy; Leukocidins; Levofloxacin; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Staphylococcal; Polymerase Chain Reaction; Serotyping | 2009 |